Clinical Trials Browser

Phase 2 × INDUSTRY × Mifepristone × Clear all

NCT00422201 2019-10-11

Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion

Phase 2 Terminated

18 enrolled 9 charts

ACTH Syndrome, Ectopic, Cushing Syndrome

NCT00881140 2012-12-19

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

Phase 2 Completed

Leiomyoma, Uterine Hemorrhage